Inflammatory macrophage dependence on NAD


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
04 2019
Historique:
received: 21 05 2018
accepted: 25 01 2019
pubmed: 13 3 2019
medline: 20 4 2019
entrez: 13 3 2019
Statut: ppublish

Résumé

The adoption of Warburg metabolism is critical for the activation of macrophages in response to lipopolysaccharide. Macrophages stimulated with lipopolysaccharide increase their expression of nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in NAD

Identifiants

pubmed: 30858618
doi: 10.1038/s41590-019-0336-y
pii: 10.1038/s41590-019-0336-y
doi:

Substances chimiques

Acrylamides 0
Cytokines 0
N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide 0
Piperidines 0
Reactive Oxygen Species 0
NAD 0U46U6E8UK
Nicotinamide Phosphoribosyltransferase EC 2.4.2.12
nicotinamide phosphoribosyltransferase, mouse EC 2.4.2.12
Electron Transport Complex III EC 7.1.1.8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

420-432

Subventions

Organisme : Wellcome Trust
ID : 201330/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI053825
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Alanna M Cameron (AM)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Angela Castoldi (A)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

David E Sanin (DE)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Lea J Flachsmann (LJ)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Cameron S Field (CS)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Daniel J Puleston (DJ)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.

Ryan L Kyle (RL)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Annette E Patterson (AE)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Fabian Hässler (F)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Joerg M Buescher (JM)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Beth Kelly (B)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Erika L Pearce (EL)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.

Edward J Pearce (EJ)

Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany. pearceed@ie-freiburg.mpg.de.
Faculty of Biology, University of Freiburg, Freiburg im Breisgau, Germany. pearceed@ie-freiburg.mpg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH